Patients with mast cell activation syndrome tolerate COVID-19 vaccines

PHOENIX — Patients with mast cell activation syndrome tolerated COVID-19 vaccination, according to an abstract presented at the American Academy of Allergy, Asthma & Immunology Annual Meeting.
“The likely situation for confirmed patients with [mast cell activation syndrome (MCAS)] is that they’re going to have the same side effects as patients who do not have MCAS, as described by the CDC,” Onyinye Iweala, MD, PhD, assistant professor of medicine in the division of rheumatology, allergy and immunology at University of North Carolina in Chapel Hill, told Healio.

PHOENIX — Patients with mast cell activation syndrome tolerated COVID-19 vaccination, according to an abstract presented at the American Academy of Allergy, Asthma & Immunology Annual Meeting.
“The likely situation for confirmed patients with [mast cell activation syndrome (MCAS)] is that they’re going to have the same side effects as patients who do not have MCAS, as described by the CDC,” Onyinye Iweala, MD, PhD, assistant professor of medicine in the division of rheumatology, allergy and immunology at University of North Carolina in Chapel Hill, told Healio.